Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Sustained-release epidural morphine effective in reducing knee surgery pain

March 14, 2005

GSK discloses three series of Gly-T1 transporter inhibitors for schizophrenia

March 11, 2005

Novel cannabinoid receptor modulators prepared at the University of Tennessee

March 11, 2005

Yamanouchi may terminate PYM-50028 licensing agreement with Phytopharm

March 11, 2005

Labopharm seeks Mexican approval for once-daily tramadol

March 11, 2005

Studies reveal safety and treatment benefits of rasagiline in Parkinson's disease

March 11, 2005

New preclinical and clinical data available for rotigotine in Parkinson's disease

March 11, 2005

Seletracetam reduces levodopa-induced dyskinesia in marmosets

March 10, 2005

Induction of HSP70 produces neuroprotective effects

March 10, 2005

Org-24461 reverses negative symptoms of schizophrenia in preclinical models / News in Context

March 10, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...